{"database":"MetabolomicsWorkbench","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["http://www.metabolomicsworkbench.org/rest/study/study_id/ST000849/mwtab"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Metabolomics"],"technology_type":["Mass Spectrometry","ESI"],"disease":["Spinal Cord Injury"],"species":["Mus Musculus"],"full_dataset_link":["http://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST000849"],"study_factor":["time pt:P90d | grouping:K6-/-","time pt:P60d | grouping:Wt","time pt:P90d | grouping:K6+/+","time pt:P21d | grouping:K6-/-","time pt:P21d | grouping:PAR1","time pt:P21d | grouping:PAR2","time pt:P21d | grouping:CTRL","time pt:P21d | grouping:K6+/+","time pt:P60d | grouping:PAR1-/-","time pt:P60d | grouping:PAR2-/-"],"tissue":["Spinal Cord"],"submitter_affiliation":["Mayo Clinic"],"sample_protocol":["Reversed phase NEGATIVE ION MODE."],"repository":["MetabolomicsWorkbench"],"metabolite_name":["linoleic","arachidonic","linolenic","stearic","palmitoleic","myristic","elaidic","EPA","palmitelaidic","palmitic","DHA","oleic"],"data_protocol":[""],"name_synonyms":["FFA, PAR, pbp2, acidum flufenamicum, par1, CG8201, acide flufenamique, F7D19.13, SXR, Sheath, f2r-a, PRR, dPAR1, dPar1, ThrR, dMARK, 3'-trifluoromethyldiphenylamine-2-carboxylic acid, AI482343, flufenamic acid, DmelCG8201, ONR1, CF2R, CG11960, ctak1, CG30131, CG30132, EMK, F7D19_13, dPAR-1, D15Ertd747e, anon-WO0210402.19, DPAR-1, Achless, PARq, fluphenamic acid, dPar-1, GPCR42, Function Recovery, SNQ3, BXR, alpha-trifluoro-m-tolyl)anthranilic acid, acido flufenamico, 27C1, SAR, Flufenaminsaeure, HTR, Gpr172b, N-(alpha, PXR, HLH1, l(2)k06323, Sheaths, Function Recoveries., alpha, mRFT1, Gpcr11, Cf2r, par-1, c-tak1, N-(3-trifluoromethylphenyl)anthranilic acid, PAR-2, emk1, HELIX-LOOP-HELIX 1, PAR-1, Myelin, l(2)27C1, emk-1, GPR11, 2-[3-(trifluoromethyl)anilino]benzoic acid, BcDNA:RH48823, par1b, emk-2, 2010003P03Rik, MARK, Par-1, DPar1, Par-1A, Par-2, PAR2, Par2, PAR1, Par1, Myelin Sheaths, CG16701, PHY RAPIDLY REGULATED 1, 2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO] BENZOIC ACID, TR"],"sample_synonyms":["backward, reversed."],"additional_accession":[]},"is_claimable":false,"name":"Targeting Myelin FFA Compostion of Kallikrein 6 Signals through PAR1 and PAR2 to Enchance Recovery of Function after SCI","description":null,"dates":{"publication":""},"accession":"ST000849","cross_references":{"TAXONOMY":["10090"]}}